Can You Walk With MS? How the Disease Affects Mobility

Most people with multiple sclerosis can walk, especially in the earlier years of the disease, but walking difficulty is one of the most common and most dreaded consequences of MS. Somewhere between half and 80 percent of people with MS develop problems with balance and gait over the course of the disease, and among those who struggle with walking, roughly 70 percent call it the single most challenging aspect of living with MS.¹ The picture is far more varied than a simple yes-or-no, though, because MS affects mobility through several distinct mechanisms, and the degree of impairment depends on where in the nervous system the damage lands, how far the disease has progressed, and even what the weather is doing on a given day.

How Common Are Walking Problems, and How Early Do They Start?

In a large survey of people with MS, about 41 percent reported difficulty walking, and 13 percent said they were unable to walk at least twice a week.¹ That leaves the majority able to walk most or all of the time, which is worth emphasizing because the wheelchair-bound image of MS that many people carry is outdated. Still, some degree of impairment can appear surprisingly early. A study tracking symptom prevalence over 30 years from disease onset found that most people noticed at least some impairment across multiple symptom domains within the first year, and severity climbed with disease duration.² Early walking problems might be subtle: a slight drag in one foot, slower-than-usual walking pace, or a tendency to tire out faster than expected. These signs often arrive well before anyone needs a cane or a wheelchair.

The practical fallout is significant. Walking problems are tightly linked to employment, social engagement, and independence. Among those with walking difficulty, only about a third were employed, and working hours dropped further as walking speed declined.¹ ³ People with MS as a group also use wheelchairs and mobility scooters more often, have more difficulty with public transport, and face reduced fitness to drive, particularly those with higher disability scores or cognitive involvement.⁴

What Actually Goes Wrong When MS Disrupts Walking

Walking seems simple, but it depends on a chain of communication between your brain, spinal cord, and peripheral nerves. MS disrupts that chain by damaging the myelin insulation around nerve fibers, which slows or blocks the electrical signals muscles rely on. The result is not one single gait problem but a cluster of them, and which ones you develop depends on where in the central nervous system the lesions form.

Three broad categories tend to drive walking trouble in MS:

Muscle weakness and spasticity: Damage to the pyramidal tracts (the nerve pathways that carry movement commands from brain to spinal cord) causes weakness in the legs. At the same time, spasticity, a kind of involuntary muscle stiffness, often develops in the calf muscles and thigh muscles. Research shows that spasticity in the ankle and knee muscles is strongly correlated with how far a person can walk, and even low levels of spasticity in the ankle and hip can start cutting into gait and balance performance.⁵ People with spasticity walk significantly more slowly and cover less distance in timed walking tests compared to those without it.⁶
Cerebellar damage: The cerebellum coordinates smooth, fluid movement. When MS lesions land there, the result is unsteady, poorly coordinated walking that looks and feels unbalanced. Cerebellar shrinkage and damage to the nerve bundles connecting the cerebellum to the rest of the brain have been clearly linked to slower walking speed and longer times to complete walking tasks.⁷
Sensory loss: Walking also requires constant feedback from the feet and joints about where the body is in space. When MS damages sensory pathways, that feedback becomes unreliable, making it harder to stay balanced, especially on uneven surfaces or in dim light.

People who fall tend to have more damage across all of these systems at once. A study comparing fallers to non-fallers with MS found that fallers had greater impairment in cerebellar, sensory, and pyramidal function, with the cerebellar differences being the largest.⁸ More than half of people with MS fall at least once each year.⁹

Motor Fatigue and the “Fading Walk”

One of the most characteristic and frustrating mobility issues in MS is motor fatigue during walking. You might feel fine stepping out the door, but five or ten minutes later your legs slow down or feel heavy, even if you are not particularly tired in the general sense. This is not ordinary tiredness. It reflects a measurable decline in walking speed over the course of sustained effort.

Studies using six-minute and longer walk tests have documented this decline in detail. Both mildly and moderately affected people with MS slow down more rapidly during prolonged walking compared to healthy individuals, and the subjective feeling of fatigue correlates more strongly with this speed decline than with average walking speed overall.¹⁰ More than a third of people with MS show measurable walking-related motor fatigue during a six-minute walk test, with the prevalence climbing to about half in those with greater disability or progressive forms of the disease.¹¹

In practice, this means someone might handle a short walk to the mailbox without trouble but struggle with a trip around the grocery store. The deceleration is also steeper in people with more damage to the pyramidal, cerebellar, or sensory systems.¹² Standard short walking tests used in the clinic can miss this phenomenon entirely, which is why longer tests are valuable for understanding someone’s real-world walking limits.

Foot Drop and How It Changes the Way You Walk

Foot drop is one of the most visible gait changes in MS. It happens when weakness in the muscles that lift the front of the foot during the swing phase of walking causes the toes to drag or catch on the ground. The result is a higher risk of tripping and a noticeably altered stride pattern.¹³ People sometimes compensate by swinging the leg outward in an arc or hiking the hip up higher with each step, both of which burn more energy and contribute to faster fatigue.

Foot drop also worsens over the course of a walk. During a six-minute walking test, people with foot drop showed a measurable loss of ankle lift by the end compared to the beginning, along with a significant drop in step rate and longer time spent with the foot on the ground during each stride, all of which translate into slower walking.¹⁴ This is a good example of how individual gait problems and motor fatigue compound each other: the foot drop itself costs extra energy, and the extra energy expenditure feeds the fatigue cycle.

Heat Sensitivity and Uhthoff’s Phenomenon

An estimated 60 to 80 percent of people with MS experience temporary worsening of symptoms when their body temperature rises, whether from hot weather, exercise, a hot bath, or a fever.¹⁵ This is known as Uhthoff’s phenomenon, named after a 19th-century physician who first described it in the context of exercise-induced vision problems.¹⁶ The underlying cause is straightforward: heat further impairs the already-compromised ability of demyelinated nerves to conduct electrical signals, effectively worsening the conduction block that MS creates.

For walking, this means that a person who manages fine in a cool room may become noticeably weaker and more unsteady outdoors in summer. The effect is temporary and reverses once body temperature drops, but it can be alarming the first time it happens, and it shapes day-to-day planning in significant ways. Cooling garments, including vests and neck wraps, have been shown in a meta-analysis to improve walking capacity, functional mobility, and subjective fatigue, and those benefits were seen in both temperate and warm conditions.¹⁷ A cooling vest may seem like a minor intervention, but for someone with significant heat sensitivity, it can be the difference between managing an errand and staying home.

When Thinking and Walking Compete

Walking is not purely a motor task. It requires ongoing cognitive input: attention, processing speed, executive function. In MS, where cognitive impairment is common alongside physical impairment, the two systems can interfere with each other in a phenomenon called cognitive-motor interference. When people with MS walk while doing a cognitive task at the same time, like mental arithmetic or a word task, their walking slows down, their strides shorten, they lift their toes less, and they spend more time with both feet on the ground.¹⁸

This matters because real-world walking almost always involves multitasking: navigating a crowded sidewalk, carrying groceries, having a conversation. People with lower cognitive performance show a larger penalty to their walking when multitasking, with greater drops in stride speed.¹⁹ Interestingly, some people whose walking looks perfectly normal in a quiet clinic hallway show clear gait deficits only under dual-task conditions, which suggests that standard clinical walking tests may underestimate real-world difficulty.¹⁸

How MS Type and Disease Course Affect the Outlook

Not all MS is the same, and the type of MS you have strongly influences how walking is affected over time. Relapsing-remitting MS, the most common form, causes episodes of worsening followed by partial or full recovery. Walking problems during a relapse may resolve substantially, especially early in the disease. Progressive forms of MS, whether primary progressive or secondary progressive, involve a steady worsening of disability without clear relapses.

Walking impairments are more than 20 percent greater in people with progressive MS compared to those with relapsing-remitting MS, even after adjusting for sex, age, weight, height, and disease duration.²⁰ Over time, people with progressive MS also show more measurable worsening on disability scales. One study following people over four years found significant disability-scale increases in the progressive group but not in the relapsing-remitting group, though gait-pattern analysis revealed that deterioration in actual walking mechanics could differ between individuals regardless of their MS type.²¹ In other words, the broad categories matter, but individual trajectories within those categories vary widely.

Medications That Target Walking

Disease-modifying therapies, the backbone of MS treatment, are effective at reducing relapses and slowing the accumulation of new brain and spinal cord lesions. However, there is minimal evidence that they reverse existing walking disability or restore ambulatory function that has already been lost.²² Their value for walking is primarily preventive: by limiting new damage, they reduce the chance that future relapses will chip away at mobility.

One medication was developed specifically to improve walking in MS. Dalfampridine (sold as Ampyra in the United States) works by blocking potassium channels on demyelinated nerve fibers. When myelin is stripped away, potassium channels that are normally hidden become exposed, causing electrical signals to leak and slow down or fail entirely. Dalfampridine plugs those leaks, allowing signals to travel more reliably.²³ Clinical trials showed that improved nerve conduction translated into measurable and patient-reported improvements in walking speed.²⁴ The drug does not work for everyone, and the benefit is modest rather than dramatic, but for responders it can meaningfully improve daily walking capacity.

Physical Rehabilitation and Exercise

Exercise and structured rehabilitation are among the most effective tools for maintaining and improving walking ability in MS. A retrospective study of an intensive, personalized physical rehabilitation program found that all clinical walking outcomes improved, with people in the moderate and severe disability groups improving the most. People with moderate gait disability improved their distance on a two-minute walk test by about 19 percent, and those with severe disability improved by about 16 percent, both exceeding the threshold for a clinically meaningful difference.²⁵

Different types of exercise appear to have different strengths. A randomized trial comparing treadmill training to progressive strength training found that treadmill walking produced greater improvement in gait quality and walking efficiency.²⁶ That does not mean strength training is unhelpful; it addresses spasticity and weakness that feed into walking problems. But for direct gait improvement, task-specific practice (actually walking) tends to outperform generic strengthening alone. The key takeaway from the rehabilitation literature is that MS-related walking decline is not entirely fixed by the disease itself. A meaningful portion of it responds to training, even in people with moderate to severe disability.

Assistive Devices for Foot Drop and Beyond

When foot drop is a persistent problem, two main devices are used to compensate for it. An ankle-foot orthosis is a lightweight brace worn inside the shoe that holds the foot at a better angle during walking. Functional electrical stimulation is a small device, usually worn below the knee, that delivers electrical pulses to the muscles responsible for lifting the foot, triggering them to contract at the right moment in the stride.

Both approaches improve walking speed. A meta-analysis of functional electrical stimulation for foot drop in MS found a meaningful increase in gait speed on short walking tests, both immediately and with ongoing use.²⁷ A large randomized trial directly comparing the two devices found that walking speed improved equally with either one over 12 months, but people using functional electrical stimulation reported higher scores on measures of self-esteem, adaptability, and perceived competence, suggesting it felt less like wearing a brace and more like natural movement.²⁸

Some people also combine dalfampridine with functional electrical stimulation. Early research has explored this combination, and the rationale makes sense: one targets the nerve conduction problem internally, the other compensates for remaining weakness externally.²⁹

Robotic Exoskeletons and Emerging Technology

For people with more severe mobility loss, robotic exoskeletons represent a newer frontier. These are powered frames worn around the legs and torso that drive walking motion with motors at the hip and knee joints. A pilot randomized trial of exoskeleton-assisted exercise rehabilitation in people with substantial MS disability found initial evidence that the approach improved functional mobility, potentially by promoting adaptive brain connectivity changes.³⁰ A separate single-group study found that exoskeleton-assisted gait training improved walking speed and reduced the metabolic cost of walking, likely by improving neuromotor coordination.³¹

Researchers are also beginning to explore whether home-based exoskeletons could serve a dual role: as both assistive devices for daily mobility and training tools for motor rehabilitation.³² The evidence here is still early stage, pilot trials and protocols rather than large confirmatory studies, but the direction is promising for people whose walking deficits are too severe for conventional therapy alone.

How Walking Is Measured in the Clinic

If you are being evaluated for walking problems in MS, two tests are used more than any others. The Timed 25-Foot Walk has you walk 25 feet as fast as you safely can while a clinician times you. It is quick, reliable, and works across a wide range of disability levels.³³ The 12-Item MS Walking Scale is a self-report questionnaire that captures how walking limitations affect your daily life. The two measure related but different things: the timed test captures your maximum physical performance in a controlled hallway, while the questionnaire captures your lived experience of walking difficulty.

Longer tests like the six-minute or two-minute walk are better at picking up motor fatigue and endurance limits that short sprints miss.³⁴ If you feel that your walking problems are worse than your clinic test results suggest, it may be worth asking your neurologist about a longer walking test or discussing how multitasking and heat affect your real-world mobility. The gap between how someone performs in a cool, quiet hallway and how they manage a busy sidewalk in July can be substantial, and that gap often goes unmeasured.